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It is almost a certainty today that every so-called "healthcare system" in the world rations care in some manner, whether by price point of insurance as in the private part of the American healthcare system or by government fiat as in Canada. This issue of Healthcare Management Forum (HMF) looks at what happens when care is rationed to the point where access to medically necessary care, service, and products is denied and how to turn the tide.
After 41 years in the workforce-industry, government, politics, and 27 in academe-I accepted the position of Executive Director of The Cameron Institute, a think tank created in 2009 to address the gaps in health, social, and economic policy analysis in Canada and around the world. Some of the articles in this issue of HMF have been written by speakers at the Institute's last Health Policy Assembly held in Banff, Alberta. Others were solicited or contributed with the express idea of addressing access.
In a really interesting article, Tiessen and Kato start off this issue with a look at Japan's healthcare system-instead of the usual UK and US suspects-which is relatively inexpensive, provides accessible services, and was established nearly 10 years before Canada's. Two aspects of Japan's system are particularly interesting. The first is that there is active competition for patients among a variety of hospital providers, which can be privately or publicly owned. The second is that prices are set centrally by a national Council, the Chuikyo, which includes payers, providers, and third-party experts, in public negotiations-a process that reduces the distorting effect of politics.
One common barrier to access is capacity-or the lack thereof. Adams, Chauhan, and Buske take a look at the gatekeeper of our "system"-the physician. The "boom" in physician supply in the 1960s and 1970s was followed by a "bust" in the 1990s and another boom in the 2000s. A large general shift is anticipated between now and 2030; the proportion of "boomers" (1946) (1947) (1948) (1949) (1950) (1951) (1952) (1953) (1954) (1955) (1956) (1957) (1958) (1959) (1960) (1961) (1962) (1963) (1964) will drop from 43% to 16% of the practicing profession; Gen Y (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) will rise 10-fold to reach 38%. Although there are current concerns about a shortage of practice opportunities for some specialties, the available data do not indicate a physician surplus on the horizon in Canada.
If the physician-to-patient ratio is not to dramatically change in the near future what about improved utilization of the physicians we do have? Value-for-money is a growing focus of such discussions. Hebert, Colasante, Ilse, and Forster report on an organization that has begun implementing a system of structured incentives which links distribution of Ministry academic physician funding to quality and performance goals, a new value-for-money allocation model.
Another common barrier to access is extraordinarily long wait times. After significant pressure, provincial governments have begun to address wait times. In an article that is sure to garner controversy, MacKinnon asserts that this problem that plagues Canadian healthcare more than most other countries is directly linked to the way that Medicare was structured. The article examines a successful strategy to reduce wait times for elective surgery in Saskatchewan, which saw wait times in the province change from being among the longest in Canada to being the shortest.
As we know, Canada is the only country in the world with a national healthcare plan that does not include drug coverage. Attara shows that the public coverage of necessary medications is an inadequate patchwork of inconsistent programs that does not always serve the very individuals they were created to help-patients who need prescribed medicines. Also, in many cases, access is not just delayed, as compared to privately insured individuals or other countries, it is flat-out denied.
Emery and Zwicker take the examination of this barrier to access to drugs one step further. For new technology and innovation, such as precision genetic diagnostics and medicines, to become part of the solution for the fiscal sustainability of Canadian Medicare, decision-makers need to change how services are priced rather than trying to restrain emerging technologies for short-term cost savings. If provincial public payers shift their thinking to be public purchasers, value considerations would direct reform of the reimbursement system to have prices that adjust with technologically driven productivity gains. Emery and Zwicker believe that this strategic shift in thinking is necessary if Canadians are to benefit from the promised benefits of innovations like precision medicine.
In a totally different vein, Tremblay offers healthcare leaders in Canada an opportunity to build a more worldly understanding of healthcare challenges focusing on postconflict countries and island/small countries. Conflict usually undermines, if it does not destroy, a country's healthcare system. Post-conflict countries offer an opportunity to consider the applicability of the determinants of policy and institutional failure to Aboriginal healthcare in Canada. Small and island countries often depend on other countries for their workforce and for specialist healthcare services. Small and island countries offer opportunities for the majority of Canadian provinces and territories to develop new approaches from novel comparator countries, with which they may have more in common than they think.
The literature clearly shows that language barriers negatively affect access to most services: health promotion/education resources, prevention activities, cancer screening, mental health services, primary care, and referral to specialized services. De Moissac and Bowen report that many minority official language speakers in Canada still experience barriers to healthcare access.
The last article in this issue tackles something that is frequently absent from discussions dealing with access to care: how access is defined and by whom. Ringer demonstrates the importance of engaging individuals and communities when defining access and developing improvement strategies, and reports on the experience and approach of one Indigenous regional health and social services authority.
We know Canada lacks capacity (the OECD keeps telling us) and we know we do not deliver value-for-money (the OECD keeps telling us this too) but denied access is a serious ethical question-however defined and however it arises. Unfortunately, none of what is written in this issue of HMF is new. Canadian healthcare suffers from cognitive and action inertia which has allowed these barriers to access to become entrenched.
Frankly, after reading this issue of our journal, I cannot help but think that Canadian healthcare needs an enema.
